The European Medicines Agency (EMA) has recently reported trends of patients having suicidal thoughts and self-injury associated with GLP-1 RA use, most specifically liraglutide and semaglutide [24]
These ampoules are intended for intramuscular injection only.
CHICAGO (February 2, 2026) With over 31 million people currently using GLP-1 drugs like Ozempic and Mounjaro, the conversation has shifted from weight loss success stories to serious legal questions
We do not guarantee uninterrupted access and are not liable for temporary outages, technical issues, or platform changes
We tailor advice according to your needs and lifestyle, while meeting your preferences
Given that it has two different mechanisms of action, it appears to have a more significant effect on weight and blood sugar than GLP-1 agonist drugs alone, such as semaglutide or liraglutide, which are both currently FDA-approved for sugar and weight control under different trade names